These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
601 related articles for article (PubMed ID: 31403940)
21. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells. Zhang P; Lu X; Shi Z; Li X; Zhang Y; Zhao S; Liu H Gene; 2019 Aug; 710():103-113. PubMed ID: 31158447 [TBL] [Abstract][Full Text] [Related]
22. Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway. Wu Q; Xiang M; Wang K; Chen Z; Long L; Tao Y; Liang Y; Yan Y; Xiao Z; Qiu S; Yi B Curr Cancer Drug Targets; 2020; 20(8):624-637. PubMed ID: 32329689 [TBL] [Abstract][Full Text] [Related]
23. Increased expression of lncRNA SNHG12 predicts a poor prognosis of nasopharyngeal carcinoma and regulates cell proliferation and metastasis by modulating Notch signal pathway. Liu ZB; Tang C; Jin X; Liu SH; Pi W Cancer Biomark; 2018; 23(4):603-613. PubMed ID: 30452404 [TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway. Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211 [TBL] [Abstract][Full Text] [Related]
25. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway. Zhou XM; Sun R; Luo DH; Sun J; Zhang MY; Wang MH; Yang Y; Wang HY; Mai SJ Oncotarget; 2016 Mar; 7(12):13634-50. PubMed ID: 26872369 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220 [TBL] [Abstract][Full Text] [Related]
27. Upregulation of lncRNA HAGLROS enhances the development of nasopharyngeal carcinoma via modulating miR-100/ATG14 axis-mediated PI3K/AKT/mTOR signals. Zhang W; Zhang Y; Xi S Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3043-3052. PubMed ID: 31334669 [TBL] [Abstract][Full Text] [Related]
28. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway. Zhang J; Zhou J; Xiao S Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of ZIP4 reverses epithelial-to-mesenchymal transition and enhances the radiosensitivity in human nasopharyngeal carcinoma cells. Zeng Q; Liu YM; Liu J; Han J; Guo JX; Lu S; Huang XM; Yi P; Lang JY; Zhang P; Wang CT Cell Death Dis; 2019 Aug; 10(8):588. PubMed ID: 31383854 [TBL] [Abstract][Full Text] [Related]
30. LncRNA LINC01305 silencing inhibits cell epithelial-mesenchymal transition in cervical cancer by inhibiting TNXB-mediated PI3K/Akt signalling pathway. Yan SP; Chu DX; Qiu HF; Xie Y; Wang CF; Zhang JY; Li WC; Guo RX J Cell Mol Med; 2019 Apr; 23(4):2656-2666. PubMed ID: 30697971 [TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA PXN-AS1-L promotes the malignancy of nasopharyngeal carcinoma cells via upregulation of SAPCD2. Jia X; Niu P; Xie C; Liu H Cancer Med; 2019 Aug; 8(9):4278-4291. PubMed ID: 31173488 [TBL] [Abstract][Full Text] [Related]
32. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts. Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-34a inhibits cell invasion and epithelial-mesenchymal transition via targeting AXL/PI3K/AKT/Snail signaling in nasopharyngeal carcinoma. Jiang C; Cheng Z; Jiang T; Xu Y; Wang B Genes Genomics; 2020 Aug; 42(8):971-978. PubMed ID: 32648233 [TBL] [Abstract][Full Text] [Related]
34. Lactoferrin mediates epithelial-mesenchymal transformation by regulating the PI3K/AKT/mTOR pathway to inhibit nasopharyngeal carcinoma metastasis. Xu M; Fan Y; Zou G; Yang Q; Xu F Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):130-135. PubMed ID: 38650146 [TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA NPCCAT1 promotes nasopharyngeal carcinoma progression via upregulating YY1. Su H; Liu L; Zhang Y; Wang J; Zhao Y Biochimie; 2019 Feb; 157():184-194. PubMed ID: 30481541 [TBL] [Abstract][Full Text] [Related]
36. Capn4 regulates Snail to promote the epithelial-mesenchymal transition of nasopharyngeal carcinoma by mediating the transcriptional activity of claudin-11. Yang F; Wang F; Gao ZS; Quang GQ; Hu HB; Zheng M Kaohsiung J Med Sci; 2023 Feb; 39(2):134-144. PubMed ID: 36354184 [TBL] [Abstract][Full Text] [Related]
37. Knockdown of ZFAS1 Inhibits Hippocampal Neurons Apoptosis and Autophagy by Activating the PI3K/AKT Pathway via Up-regulating miR-421 in Epilepsy. Hu F; Shao L; Zhang J; Zhang H; Wen A; Zhang P Neurochem Res; 2020 Oct; 45(10):2433-2441. PubMed ID: 32725369 [TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway. Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903 [TBL] [Abstract][Full Text] [Related]
39. Acylglycerol kinase promotes the stemness of nasopharyngeal carcinoma cells by promoting β-catenin translocation to the nucleus through activating PI3K/Akt pathway. Zhao Q; Sun P; Qin S; Liu J Environ Toxicol; 2020 Dec; 35(12):1299-1307. PubMed ID: 32652857 [TBL] [Abstract][Full Text] [Related]
40. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis. Liu ZB; Wang JA; Lv RQ Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]